Juha Ranti
Areas of expertise
Expertese
Expertese
Publications
- Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcome analysis of the CLL13/GAIA trial (2026)
- Blood
(A1 Refereed original research article in a scientific journal) - Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia (2025)
- New England Journal of Medicine
(A1 Refereed original research article in a scientific journal) - Long term follow-up of MRD guided treatment of Ibrutinib plus Venetoclax for Relapsed CLL: phase 2 VISION/HO141 trial (2025)
- Blood Advances
(A1 Refereed original research article in a scientific journal) - Real-world study on patient characteristics, treatment patterns and outcomes for treated patients with chronic lymphocytic leukemia during 2013–2022 in Finland (2025)
- Annals of Hematology
(A1 Refereed original research article in a scientific journal) - Ohjelmoituneen solukuoleman muokkaajat leukemioissa (2024)
- Duodecim
(A2 Refereed review article in a scientific journal ) - Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy (2024)
- European Journal of Clinical Microbiology and Infectious Diseases
(A1 Refereed original research article in a scientific journal) - Treatment and clinical outcomes of patients with acute myeloid leukemia in Finland 2010-2020: A retrospective analysis of electronic health records (2024)
- European Journal of Haematology
(A1 Refereed original research article in a scientific journal) - Clinical and healthcare burden of disease associated with cytomegalovirus in allogeneic hematopoietic stem cell transplantation - A retrospective single-center study (2022)
- Transplant Infectious Disease
(A1 Refereed original research article in a scientific journal) - Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial (2022)
- Lancet Oncology
(A1 Refereed original research article in a scientific journal) - Characterization of real-world treatment practices and outcomes among patients with chronic lymphocytic leukemia treated in a Finnish tertiary center (2021)
- eJHaem : eJournal of Haematology
(A2 Refereed review article in a scientific journal )



